Sonova (OTCMKTS:SONVY) Sets New 52-Week High – Here’s Why

Shares of Sonova Holding (OTCMKTS:SONVY) reached a new 52-week high on Monday. The stock traded as high as $69.66 and last traded at $69.66, with a volume of 739 shares. The stock had previously closed at $68.25.

Analyst Ratings Changes

SONVY has been the subject of a number of research analyst reports. The Goldman Sachs Group raised Sonova from a “hold” rating to a “buy” rating in a research note on Thursday, October 8th. UBS Group raised Sonova from a “hold” rating to a “buy” rating in a research report on Wednesday, July 22nd. Finally, Citigroup reiterated a “sell” rating on shares of Sonova in a report on Friday, July 24th. One equities research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating, two have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, Sonova presently has an average rating of “Moderate Buy”.

Sonova Trading Up 0.6%

The company has a debt-to-equity ratio of 0.51, a current ratio of 1.75 and a quick ratio of 1.43. The firm has a 50 day moving average of $61.18 and a two-hundred day moving average of $53.20.

About Sonova

Sonova Holding AG is a Switzerland-based hearing-care company that develops, manufactures and distributes solutions for people with hearing loss. Its portfolio includes hearing aids, cochlear implants, hearing implants, wireless communication products and related accessories and services.

The company markets products under several brands, including Phonak, Unitron and Advanced Bionics. Sonova also operates hearing-care businesses and retail networks that provide hearing assessments, device fitting, rehabilitation support and after-sales services.